AstraZeneca, Daiichi drug extends survival in hard-to-treat breast cancer | BioPharma Dive

Retrieved on: 2025-10-06 20:58:10

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Daiichi drug extends survival in hard-to-treat breast cancer | BioPharma Dive. View article details on hiswai:

Excerpt

The results could pave the way for Datroway to supplant chemotherapy in certain triple-negative tumors, adding to existing clearances in other ...

Article found on: www.biopharmadive.com